Delivery Order SPE2DB20D3303-SPE2DB24FA0ZK
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,080.28, is a delivery order for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024 and is a Firm Fixed Price contract. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
- This is a $6,519.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRIUMEQ 600-50-300 MG TABLET in quantities of 30. The contract has an ultimate completion date of July 7, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,693.16, is for the procurement of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET in quantities of 30s, with a firm fixed price and a ceiling value of $16,631.30. The order has an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,519.84 contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, with a performance period ending on January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET in quantities of 30s, with a ceiling value of $6,519.84 and a completion date of June 18, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $99,444.91 and a performance period ending on July 11, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a $10,336.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,593.36, covers the delivery of TRIUMEQ 600-50-300 MG TABLET in quantities of 30s. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 6, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, with a ceiling value of $81,174.55 and an ultimate completion date of January 10, 2024. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB24FA0ZKDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,080.28, is for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024 and is a firm fixed-price type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is likely a task order issued under that broader IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 7/12/24 |